ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,942, issued on May 13, was assigned to Biohaven Therapeutics Ltd. (Tortola, British Virgin Islands).
"Riluzole prodrugs and their use" was invented by Jay Edward Wrobel (Lawrenceville, N.J.), Allen B. Reitz (Lansdale, Pa.), Jeffrey Claude Pelletier (Lafayette Hill, Pa.), Garry Robert Smith (Royersford, Pa.) and Haiyan Bian (Princeton, N.J.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Pharmaceutical compositions of the invention include substituted riluzole prodrugs useful for the treatment of cancers including melanoma, breast cancer, brain cancer, and prostate cancer through the release of riluzole. Prodrugs of riluzole have enhanced stability to...